ATR-101

· Millendo Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ATR-101, covering 2017-11-06 to 2021-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome [Phase 2]